ERBB2 and breast cancer: For human epidermal growth factor receptor 2 (HER2)-positive patients, circulating miR-373 was reported to be upregulated [24] and, in another Chinese study [53], it was shown that the circulating level of miR-106a-5p and miR-20b-5p was increased in HER2-negative BC patients.